Genesis Biosystems Inc.

Genesis Biosystems is a global manufacturer and distributor of innovative aesthetic technologies and skin rejuvenation solutions. The company specializes in dermatological and cosmetic treatment systems designed for practitioners in dermatology, medical spas, plastic surgery, cosmetic surgery, and oral maxillofacial surgery. Their primary product is the DermaFrac® system, a microdermabrasion and serum infusion device that delivers customizable skin rejuvenation treatments. The platform enables practitioners to infuse multiple proprietary serums (including Rejuvenate, Growth Factor, and Hydrate formulations) simultaneously during microdermabrasion procedures, targeting signs of aging such as fine lines, skin texture, firmness, and hyperpigmentation. Genesis Biosystems serves practitioners worldwide with a focus on delivering consistent, predictable clinical outcomes and strong return on investment through high-frequency treatment protocols and package sales models. The company positions its devices as easy-to-use, pain-free, and capable of producing immediate visible results with cumulative benefits over multiple sessions. Practitioners report performing 25–30 treatments per week with high patient satisfaction and package adoption rates. The product portfolio supports multiple treatment modalities, enabling customization for diverse patient demographics and clinical goals. Genesis Biosystems operates a global distribution and support infrastructure, with direct practitioner engagement through a contact-based sales model.